Disease progression rates in ambulatory Duchenne muscular dystrophy by steroid type, patient age and functional status
Aim: To examine benefits of corticosteroids for Duchenne muscular dystrophy (DMD) by age and disease progression. Methods: Data from daily steroid users (placebo-treated) were pooled from four phase 2b/3 trials in DMD. Outcomes assessed overall and among subgroups included changes from baseline to 4...
Saved in:
Main Authors: | Craig M McDonald (Author), Jessica R Marden (Author), Perry B Shieh (Author), Brenda L Wong (Author), Henry Lane (Author), Adina Zhang (Author), Ha Nguyen (Author), Molly Frean (Author), Panayiota Trifillis (Author), Karyn Koladicz (Author), James Signorovitch (Author) |
---|---|
Format: | Book |
Published: |
Becaris Publishing Limited,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1989) -
Disease progression modeling of the North Star Ambulatory Assessment for Duchenne Muscular Dystrophy
by: Jennifer E. Hibma, et al.
Published: (2023) -
Theragnosis for Duchenne Muscular Dystrophy
by: Leonela Luce, et al.
Published: (2021) -
Muscular Fatigue in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995) -
Glucocorticoids for Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2013)